[AMRX] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
02-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -255.62%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 2,212,304 2,093,669 1,992,523 1,626,373 1,662,991 1,033,654 1,018,225 13.79%
PBT -248,127 31,366 -35,780 -220,242 -202,722 171,323 214,821 -
Tax 6,662 11,196 -104,358 383,331 -1,419 1,998 5,395 3.57%
NP -254,789 20,170 68,578 -603,573 -169,726 167,648 207,378 -
Tax Rate - -35.69% - - - -1.17% -2.51% -
Total Cost 2,467,093 2,073,499 1,923,945 2,229,946 1,832,717 866,006 810,847 20.36%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -11.52 0.96 3.44 -37.11 -10.21 16.22 20.37 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -1.69 0.14 0.47 -4.57 -1.33 1.46 1.81 -
EPS Diluted -1.69 0.13 0.46 -4.57 -1.33 1.46 1.81 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.